Effect of antioxidant supplement TwendeeX on prevention of dementia
Not Applicable
- Conditions
- mild cognitive impairment post stroke
- Registration Number
- JPRN-UMIN000026268
- Lead Sponsor
- Departments of Neurology, Dentistry and Pharmaceutical Sciences, Graduate School of Medicine, Okayama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
dementia due to diffuse Lewy body disease, frontotemporal lobe dementia, Huntington's disease, idiopathic normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, cotricobasal degeneration, multiple system atrophy, encephalitis, meningitis, head trauma patients with major depression, bipolar disorder, alcoholism, drug dependence, or serious disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effect of TwendeeX on cognition (MMSE, HDS-R, and FAB) compared with Twendeex placebo at 6 months and 12 months
- Secondary Outcome Measures
Name Time Method